Loading...

Loading...

Analyzing COFEPRIS’ Regulatory Guidelines for Biosimilars
By Juan Luis Serrano Leets - Thu, 06/06/2024 - 08:00
COFEPRIS guidelines set an action plan based on regulatory certainty through which companies can invest in the sector, explains Juan Luis Serrano.

https://mexicobusiness.news/tag/ip-law
More Health
Midterm Elections’ Impact on Healthcare
By Miriam Bello - Mon, 06/14/2021 - 15:05
After many controversial reform proposals during AMLO’s administration, the sector sees a calmer future.
Understanding Changes to the IP Law and Sanitary Registration
By Agustin Azcatl Romero - Thu, 10/29/2020 - 14:33
This year, the sector, and mainly the pharmaceutical sector, was subject to multiple changes. Agustin Azcatl explains the changes.
An Expert Look Into the New IP Law for the Healthcare Sector
By Miriam Bello - Tue, 10/27/2020 - 16:38
What will the new IP law bring to the pharmaceutical industry?
What's up with Mining in Mexico into 4T's Age?
By Jesús Enrique Pablo-Dorantes - Wed, 09/30/2020 - 10:00
Mining requires more information and certainty to successfully drive ongoing projects. However, a cloud of uncertainty is blocking its success.
IP Protection For Innovative Companies
By Miriam Bello - Thu, 09/17/2020 - 09:11
With legal and engineering expertise, S&S looks to fill IP protection vacuums that make pharmaceutical, chemistry & biotechnology companies vulnerable
In Mexico, Eight Out of 10 People Consume Counterfeit Products
By Alessa Flores - Tue, 09/01/2020 - 14:11
Product piracy is no longer reserved for luxury product. Many other sectors have been hit, including pharma.
USMCA Entry Demands Amendments to Mexican Regulations
By Ingrid Ortiz - Mon, 08/10/2020 - 13:25
The modernization of the USMCA treaty should represent an opportunity for the Mexican government to provide clear guidelines to the health industry.
Mexico’s Coming Legal Challenges in IP During COVID-19 Pandemic
By Fernando Becerril - Mon, 08/03/2020 - 09:13
USMCA introduces changes to intellectual property that will be the next challenges. Fernando Becerril Orta discusses ways to overcome these challenges